Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Cancer-targeting mechanism under development

  • Stop blaming the moon: Intelligent people can develop strong entirely incorrect beliefs

  • Wearable technology can help with public speaking

  • Intelligent neuroprostheses mimic natural motor control

  • 'Wikipedia' for neurons created

  • Mother's diet influences weight-control neurocircuits in offspring

  • Rate of opioid misuse is around 25 percent, addiction rate 10 percent, reports study

  • Prototype 'nanoneedles' generate new blood vessels in mice, paving way for new regenerative medicine

  • Component of red grapes, wine could help ease depression

  • Crowdsourced tool for depression

  •